Global Zika Virus Testing Market Set to Expand Growth to USD 6.8 Million by 2033

The global Zika virus testing market is poised for substantial growth, according to a new forecast by Future Market Insights (FMI). From USD 4.9 million in 2023, the market is expected to reach USD 6.8 million by 2033, exhibiting a compound annual growth rate (CAGR) of 3.4% during the forecast period.

The primary driver behind this growth is the increasing incidence of Zika virus infections worldwide. With the healthcare sector grappling with numerous viral outbreaks in the 21st century, including notable ones like SARS, Chikungunya, Swine Flu, and Zika Virus, the demand for advanced diagnostic tools has intensified.

Request A Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2913

Key factors contributing to the rise in Zika virus testing include the emergency authorization of point-of-care testing (POCT), technological advancements in RNA therapy for Zika virus, and enhanced research and development efforts in the field.

“With advancements in diagnostic methodologies, the healthcare industry has been able to develop more effective diagnostics and treatments for Zika virus infection,” commented a spokesperson from Future Market Insights. “Techniques such as viral isolation and detection of viral antigens, nucleic acids, and antibodies are pivotal in laboratory testing for Zika virus.”

The market for Zika virus testing is expected to witness significant innovation and adoption of cutting-edge technologies in the coming years, further enhancing the diagnostic accuracy and efficiency of testing methods.

Key Takeaways: Zika Virus Testing Market (2023-2033)

• The market is expected to witness moderate growth, with estimations ranging from a CAGR of 3.4% (FMI) by 2033.
• Despite a significant rise between 2017 and 2020, driven by point-of-care testing advancements, the market is projected to have a steadier growth trajectory moving forward.
• The market size estimations vary, with figures ranging from over US$ 4.7 million (2022) to US$ 4.9 million (2023) depending on the source.
• Rising Zika virus infections are a primary driver for market growth.
• Early and accurate detection, particularly for pregnant women, is crucial to prevent birth defects associated with Zika.
• Molecular tests, like RT-PCR, are expected to hold a dominant share due to their accuracy, with growing adoption of multiplex assays for simultaneous detection of multiple pathogens.
• Point-of-care tests are gaining traction for faster turnaround times and bedside results.
• The market plays a vital role in public health strategies by enabling timely interventions and preventing outbreaks.

Get Customization on This Report: https://www.futuremarketinsights.com/customization-available/rep-gb-2913

As per FMI’s analysis, the following players operate within the global zika virus testing market:

Prominent players in the Zika virus testing market are increasingly focusing on integrating advanced testing methods to achieve faster turnaround times and expedited results. This enables clinicians to recommend timely treatment strategies for patients diagnosed with the infection. These companies also leverage strategic partnerships with various institutions and enterprises to broaden their market presence.

For instance, Creative Diagnostics provides the Recombinant Zika Virus Envelope protein test featuring Histidine tags. This protein interacts with both IgG and IgM antibodies, ensuring accurate diagnostic outcomes. With a purity exceeding 85%, it is available in 1 mg vials. Additionally, Creative Diagnostics offers the Recombinant Zika Virus NS1 protein test as part of their comprehensive testing solutions.

• In March 2022, The International Arbovirus Project was started by the World Health Organization. Initiated by the World Health Organization, the Global Arbovirus Initiative Zika, Dengue, Yellow fever, Chikungunya, and other Arboviruses are currently posing a danger to public health around the globe. By assembling a coalition of important partners, this integrated program is likely to improve the coordination, communication, capacity-building, research, readiness, and reaction required to reduce the rising risk of epidemics caused by these illnesses.

Key Players:

• EUROIMMUN US Inc.
• Creative Diagnostics
• Quest Diagnostics
• Artron Laboratories Inc.
• RapiGEN Inc.
• GenBody Inc.
• JAJ International Inc.
• LumiQuick Diagnostics Inc.
• Biocan Diagnostics Inc.
• NECTAR LIFESCIENCES LTD.
• Luminex Corporation
• ARUP Laboratories
• Abbott Molecular Inc.
• Hologic
• Vela Diagnostics

Full Report Revealed: https://www.futuremarketinsights.com/checkout/2913

Key Segments Covered:

Test Type:

• Rapid IgG/IgM Test
• ELISA Test

End-User:

• Hospitals & Clinics
• Private Commercial Laboratories
• Government/Publicly Funded Programs

Region:

• North America & Europe (USA, United Kingdom, Germany, Spain, France, Italy, and the Rest of Europe)
• Latin America (Brazil, Mexico, Colombia, and the Rest of LATAM)
• Central America (Costa Rica, Nicaragua, Guatemala, and the Rest of Central America)
• Caribbean (Puerto Rico and the Rest of the Caribbean)
• South East Asia (Thailand, Singapore, Vietnam, and the Rest of South East Asia)
• Rest of the World (North Africa and South Africa)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube